Myriad Genetics, Inc. is discontinuing development of tarenflurbil, also known as Flurizan, after the investigational treatment for Alzheimer’s disease failed to achieve significance on the co-primary endpoints –…
Scott M. Strayer, MD, MPH, Assistant Professor of Family Medicine and Public Health Services, University of Virginia Health System, Charlottesville, VA, discusses the importance of social media in…
Researchers have found that contrast materials used in radiology may cause less frequent and less severe damage to the kidneys than previously thought. References and Resources Baumgarten DA,…
Stanley Samuel, MD, discusses difficulties physicians may encounter in matching in a residency without U.S. clinical experience. If you have a similar experience to Dr. Samuel, click below…
Brenda J. Hoffman, MD, Professor, Division of Gastroenterology, Medical University of South Carolina, Charleston, SC, discusses colon cancer screening in the African-American population. References and Resources Sharma S,…
Fred A. Crawford Jr., MD, Horace G. Smithy Professor of Surgery, Head of Cardiothoracic Surgery, Medical University of South Carolina, Charleston, SC, discusses the advantages of a unique…
Ann L. Kellams, MD, Assistant Professor of Clinical Pediatrics, University of Virginia Health System, Charlottesville, VA, discusses the complications associated with late-preterm birth. References and Resources Delpisheh A,…
Casey Kerrigan, MD, MS, Department Chair, Professor of Physical Medicine and Rehabilitation, University of Virginia Health System, Charlottesville, VA, discusses the importance of gait mechanics. References and Resources…
Jaime Landman, MD, Minimally Invasive Urology, Columbia University Medical Center, New York, NY, discusses kidney stone management. References and Resources Steggall MJ, Omara M. Urinary tract stones: types,…
Christine L. Lau, MD, Assistant Professor of Surgery, Department of Surgery, Division of Thoracic and Cardiovascular Surgery, University of Virginia Health System, Charlottesville, VA, discusses the statistics of…
Rasagiline 1 mg tablets slow the progression of Parkinson’s disease, according to Phase III trial data. From our partners at VerusMed VerusMed.com Sponsored by The Doctor’s Channel
